Description
Recombinant monoclonal antibody to CEACAM1. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma C5-1X/8.
Target
CEACAM1
Target Alias Names
CD66a, Carcinoembryonic antigen-related cell adhesion molecule 1, Biliary glycoprotein 1, BGP-1, BGPI
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression